Expression of Cholera Toxin B–Lumbrokinase Fusion Protein in Pichia pastoris—The Use of Transmucosal Carriers in the Delivery of Therapeutic Proteins to Protect Rats Against Thrombosis

详细信息    查看全文

• 作者：Guan Chunfeng (1)
  Li Xiaozhou (2)
  Wang Gang (1)
  Ji Jing (1)
  Jin Chao (1)
  Tchouopou Lontchi Josine (3)
  
• 关键词：Lumbrokinase ; Cholera toxin B ; subunit ; Transmucosal carriers ; Thrombosis
• 刊名：Applied Biochemistry and Biotechnology
• 出版年：2013
• 出版时间：January 2013
• 年：2013
• 卷：169
• 期：2
• 页码：636-650
• 全文大小：503KB
• 参考文献：1. Alisky, J. M., van de Wetering, C. I., & Davidson, B. L. (2002). / Experimental Neurology, 178, 139-46. CrossRef
  2. Arêas, A. P. M., Oliveira, M. L. S., Miyaji, E. N., Leite, L. C. C., Araújo Aires, K., Dias, W. O., et al. (2004). / Biochemical and Biophysical Research Communications, 321, 192-96. CrossRef
  3. Arakawa, T., Yu, J., Chong, D. K. X., Hough, J., Engen, P. C., & Langridge, W. H. R. (1998). / Nature Biotechnology, 16, 934-38. CrossRef
  4. Befus, N., & Langridge, W. H. R. (2000). / Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 43, 116-20. CrossRef
  5. Bekemeier, H., Hirschelmann, R., & Giessler, A. J. (1984). / Biomedica Biochimica Acta, 43, S347–S350.
  6. Bergerot, I., Ploix, C., Petersen, J., Moulin, V., Rask, C., Fabien, N., et al. (1997). / Proceedings of the National Academy of Sciences, 94, 4610-614. CrossRef
  7. Bertelli, A., Bertelli, A. A., Galmozzi, G., Giovannini, L., & Mian, M. (1993). / Drugs under Experimental and Clinical Research, 19, 75-8.
  8. Bradford, M. M. (1976). / Analytical Biochemistry, 72, 248-54. CrossRef
  9. Fan, Q., Wu, C., Li, L., Fan, R., Wu, C., Hou, Q., et al. (2001). / Biochimica et Biophysica Acta (BBA)—General Subjects, 1526, 286-92. CrossRef
  10. Gong, Z., Jin, Y., & Zhang, Y. (2007). / Vaccine, 25, 1444-451. CrossRef
  11. Gresele, P., Momi, S., Berrettini, M., Nenci, G. G., Schwarz, H. P., Semeraro, N., et al. (1998). / The Journal of Clinical Investigation, 101, 667-76. CrossRef
  12. Guan, C., Wang, G., Ji, J., Wang, J., Wang, H., & Tan, M. (2008). / Journal of Sol–Gel Science and Technology, 48, 369-77. CrossRef
  13. Hamman, J. H., Enslin, G. M., & Kotzé, F. A. (2005). / BioDrugs, 19, 165-77. CrossRef
  14. Heath, J. P. (1996). / Cell Biology International, 20, 139-46. CrossRef
  15. Holmgren, J., Harandi, A. M., & Czerkinsky, C. (2003). / Expert Review of Vaccines, 2, 205-17. CrossRef
  16. Huston, J. S., Levinson, D., Mudgett-Hunter, M., Tai, M. S., Novotny, J., Margolies, M. N., et al. (1988). / Proceedings of the National Academy of Sciences of the United States of America, 85, 5879-883. CrossRef
  17. Jin, L., Jin, H., Zhang, G., & Xu, G. (2000). / Clinical Hemorheology and Microcirculation, 23, 213-18.
  18. Kim, T. G., & Langridge, W. H. R. (2003). / Plant Cell Reports, 21, 884-90.
  19. Kipnes, M., Dandona, P., Tripathy, D., Still, J. G., & Kosutic, G. (2003). / Diabetes Care, 26, 421-26. CrossRef
  20. Kod'ousek, R., Jezdinsky, J., & Krajci, D. (2007). / Medical Principles and Practice, 16, 360-66. CrossRef
  21. Kumada, T., Ishihara, M., Ogawa, H., & Abiko, Y. (1980). / Thrombosis Research, 18, 189-03. CrossRef
  22. Laemmli, U. K. (1970). / Nature, 227, 680-85. CrossRef
  23. Lee, C. K., Shin, J. S., Kim, B. S., Cho, I. H., Kim, Y. S., & Lee, E. B. (2007). / Archives of Pharmacal Research, 30, 475-80. CrossRef
  24. Lencer, W. I. (2001). / American Journal of Physiology—Gastrointestinal and Liver Physiology, 280, G781–G786.
  25. Li, D., O’Leary, J., Huang, Y., Huner, N., Jevnikar, A., & Ma, S. (2006). / Plant Cell Reports, 25, 417-24. CrossRef
  26. Limaye, A., Koya, V., Samsam, M., & Daniell, H. (2006). / The FASEB Journal, 20, 959-61. CrossRef
  27. Ling, H., Boodhoo, A., Hazes, B., Cummings, M. D., Armstrong, G. D., Brunton, J. L., et al. (1998). / Biochemistry, 37, 1777-788. CrossRef
  28. McKenzie, S. J., & Halsey, J. F. (1984). / The Journal of Immunology, 133, 1818-824.
  29. Mihara, H. (1983). / Thrombosis and Haemostasis, 50, 258.
  30. Mustata, G., & Dinh, S. M. (2006). / Critical Reviews in Therapeutic Drug Carrier Systems, 23, 111-35. CrossRef
  31. Nakajima, N., Ishihara, K., Sugimoto, M., Sumi, H., Mikuni, K., & Hamada, H. (1996). / Bioscience, Biotechnology, and Biochemistry, 60, 293-00. CrossRef
  32. Nakajima, N., Mihara, H., & Sumi, H. (1993). / Bioscience, Biotechnology, and Biochemistry, 57, 1726-730. CrossRef
  33. Philipose, S., Konya, V., Sreckovic, I., Marsche, G., Lippe, I. T., Peskar, B. A., et al. (2010). / Arteriosclerosis, Thrombosis, and Vascular Biology, 30, 2416-423. CrossRef
  34. Riewald, M., & Ruf, W. (2003). / Critical Care, 7, 123-29. CrossRef
  35. Shah, R. B., Ahsan, F., & Khan, M. A. (2002). / Critical Reviews in Therapeutic Drug Carrier Systems, 19, 135-69. CrossRef
  36. Tomoko, N., Fumio, T., Naotoshi, T., Takashi, Y., Takeshi, A., Yoshihiro, H., et al. (2009). / Journal of Veterinary Medical Science, 71, 995-000. CrossRef
  37. Van Der Lubben, I. M., Konings, F. A. J., Borchard, G., Verhoef, J. C., & Junginger, H. E. (2001). / Journal of Drug Targeting, 9, 39-7. CrossRef
  
• 作者单位：Guan Chunfeng (1)
  Li Xiaozhou (2)
  Wang Gang (1)
  Ji Jing (1)
  Jin Chao (1)
  Tchouopou Lontchi Josine (3)
  
  1. School of Agriculture and Bioengineering, Tianjin University, Tianjin, 300072, People’s Republic of China
  2. Department of Medical Genetics, Tianjin Medical University General Hospital, Tianjin, 300072, People’s Republic of China
  3. School of Environmental Science and Engineering, Tianjin University, Tianjin, 300072, People’s Republic of China
  
• ISSN：1559-0291

文摘

Cholera toxin B-subunit (CTB) has been widely used to facilitate antigen delivery by serving as an effective mucosal carrier molecule for the induction of oral tolerance. However, whether CTB can be used as a transmucosal carrier in the delivery of not only vaccines but also therapeutic proteins has not been widely studied. Thus, we investigate here the concept of receptor-mediated oral delivery of lumbrokinase (LK) proteins which is an important fibrinolytic enzyme derived from earthworm. CTB and LK, separated by a furin cleavage site, was expressed via Pichia pastoris. The activity and proper folding of recombinant protein in yeast were confirmed by Western blot analysis, fibrin plate assays, and GM1-ganglioside ELISA. Following oral administration of recombinant protein, the thrombosis model of rats and mice revealed that the oral treatment of rCTB–LK has a more significant anti-thrombotic effect on animals compared with rLK. It is possible to conclude that CTB can successfully enhance its fusion protein LK to be absorbed. The use of CTB as a transmucosal carrier in the delivery of not only vaccines but also therapeutic proteins was supported.